|

single dose of CNCT19 Clinical Trials

4 actively recruiting trials

Pipeline

Early 1: 1Phase 2: 2Phase 1/2: 1

Top Sponsors

  • Juventas Cell Therapy Ltd.4

Indications

  • Cancer3
  • Lupus Erythematosus, Systemic1
  • Lupus1
  • B-cell Acute Lymphoblastic Leukemia1
  • Relapsed or Refractory Acute Lymphoblastic Leukemia1

Other4 trials

A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)
Phase 1/2
Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia
Phase 2
Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases
Early 1
Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.